ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Living Donor Liver Transplantation for High MELD Score Patients

H. Chou, C. Lee, R. Soong, T. Wu, T. Wu, K. Chan, W. Lee

Division of Liver and Transplantation Surgery, Department of General Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan

Meeting: 2013 American Transplant Congress

Abstract number: D1615

Related Abstracts
  • MELD Score Does Not Predict Outcome of Living Donor Liver Transplantation
  • Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score

Background: Liver transplantation is the only effective treatment for the very sick liver failure patients. For the success of liver transplantation, it is better to have good donors for very sick patients. However, liver donation is very short in Asian countries. Liver donor liver transplantation is the only way to rescue the very sick patients. The aim of this study is to examine the results of living donor liver transplantation for the patients with high the model of end-stage liver disease (MELD) scores.

Materials and methods: The living donor liver transplant recipients with MELD score more than or equal to 25 were included in this study. The clinical profiles were recorded and survival rate was calculated.

Results: From June 2004 to Oct. 2012, totally 61 patients receiving ABO-compatible living donor liver transplantation were included in this study. The disease entities for transplantation were 37 for hepatitis B-, 8 for hepatitis C-, 8 for alcoholic liver cirrhosis-, 4 for drug-induced and 4 for other disease-related liver failure. The mean MELD score was 31.4±5.9. Graft-recipient weight ratio was 1.05±0.26%. Among these patients, 13 (21.3%) patients died within 3 months. Ten of them died of infection and multiple organ failure, 2 patients died of acute humoral rejection and one patient died of pulmonary embolism. The 3-month, 1-year and 3-year survival rates were, 76.9%, 68.2% and 61.9%, respectively. MELD and GRWR could not predict patients’ survival.Conclusion: Partial graft transplantation still can be used to rescue very sick patients and achieve 68.2% of one-year survival in this study. Infection is the most etiology to cause early patient death. Conclusively, living donor liver transplantation to rescue very sick patients is feasible, however, infection control is essential.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Chou H, Lee C, Soong R, Wu T, Wu T, Chan K, Lee W. Living Donor Liver Transplantation for High MELD Score Patients [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/living-donor-liver-transplantation-for-high-meld-score-patients/. Accessed April 18, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.